Nov 24, 2008 - Genzyme Corporation announced today that it has filed a supplemental New Drug Application with the U.S. Food and Drug Administration for the use of Clolar (clofarabine) to treat adult patients with acute myeloid leukemia (AML).
The details can be read here.
No comments:
Post a Comment